bexarotene has been researched along with probucol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agujetas, VR; Albrecher, NM; Carmen Kober, A; Colell, A; de Dios, C; Fanaee-Danesh, E; Gali, CC; Madeo, F; Malle, E; Manavalan, APC; Panzenboeck, U; Reiter, M; Stracke, A; Sun, Y; Tadic, J; Tam-Amersdorfer, C; Zandl-Lang, M | 1 |
1 other study(ies) available for bexarotene and probucol
Article | Year |
---|---|
Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
Topics: ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Apolipoproteins E; ATP Binding Cassette Transporter 1; Bexarotene; Blood-Brain Barrier; Cholesterol; Down-Regulation; Endothelial Cells; Female; Mice; Mice, Inbred C57BL; Mice, Transgenic; Probucol; Protective Agents; Swine; Xanthophylls | 2019 |